ENVESTNET ASSET MANAGEMENT INC
Position in NAMS — NewAmsterdam Pharma Co N.V.
CIK 1407543
Berwyn, PA
Position in NAMS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$525,972
+$28,217 QoQ
Shares Held
15,520
-0.2% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#128
of 198 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $894,401,954 across 107 Biotechnology names. NAMS ranks #76 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
487,627 | $242,218,959 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,838 | $68,488,386 | |
| 3 | EXEL |
Exelixis, Inc.
|
949,669 | $51,671,490 | |
| 4 | ARGX |
Argenx SE
|
55,346 | $51,348,358 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
136,395 | $41,058,986 | |
| 6 | INSM |
INSMED Inc
|
336,997 | $35,930,620 | |
| 7 | RPRX |
Royalty Pharma plc
|
513,096 | $28,769,292 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
713,946 | $25,266,548 |
All Filings in NAMS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $525,972 | 15,520 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $497,755 | 15,550 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $616,425 | 17,572 | Shares | Sole | 2026-02-10 | |
| 2024-12-31 | $240,526 | 9,359 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $300,410 | 18,097 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $368,140 | 19,164 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $213,772 | 9,039 | Shares | Sole | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||